Add BrightSurf on Google Email

UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies

A new study by UNC researchers provides evidence that could help improve CF pharmacotherapies. They found that a mutant CFTR protein loses its ability to function properly when in the presence of two drugs, suggesting that drug developers should take this destabilization effect into account.

SourceUniversity of North Carolina Health Care·JournalScience Translational Medicine·DateJul 23, 2014

Fat damages the lungs of heavy drinkers

Researchers at Thomas Jefferson University found that alcohol consumption leads to a buildup of fat in the lungs, weakening the immune system and increasing the risk of pneumonia and acute respiratory distress syndrome. This discovery offers a potential new explanation for why heavy drinkers are more susceptible to lung disease.

SourceThomas Jefferson University·JournalAmerican Journal of Respiratory Cell and Molecular Biology·DateJun 30, 2014

JCI online ahead of print table of contents for June 2, 2014

Researchers discover that mucin concentration in cystic fibrosis airway secretions contributes to decreased mucus clearance and promotes lung infection and inflammation. Meanwhile, an aptamer-based strategy delivers a specific siRNA to tumor cells and Tregs, reducing STAT3 expression and promoting anti-tumor responses.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 2, 2014

Artificial lung the size of a sugar cube

Researchers have created an innovative 3D test system that allows them to simulate human body functions, enabling the development of more effective cancer treatments. The artificial lung model, no bigger than a sugar cube, can be used to analyze treatment resistance and metastasis formation, potentially leading to personalized medicine.

Vitamin E in canola and other oils hurts lungs

A new Northwestern University study reveals that high gamma-tocopherol levels, found in soybean, corn, and canola oils, are associated with decreased lung function and increased asthma risk. In contrast, alpha-tocopherol, found in olive and sunflower oils, is linked to better lung function.

SourceNorthwestern University·JournalRespiratory Research·DateMay 20, 2014

'Beneficial inflammation' may promote healing in pulmonary fibrosis

A study published in the American Journal of Respiratory Cell and Molecular Biology suggests that TNF-α, a pro-inflammatory cytokine, accelerates lung recovery and reduces scar tissue in mice with pulmonary fibrosis. The researchers found that inflammation can be beneficial during the healing process, rather than just causing scarring.

SourceNational Jewish Health·JournalAmerican Journal of Respiratory Cell and Molecular Biology·DateApr 25, 2014

Plague alters cell death to kill host

Scientists have discovered how Yersinia pestis alters cell death pathways to kill host cells and cause pneumonic plague. The study reveals that the bacterium destroys Fas ligand, a molecule that stimulates apoptosis, allowing it to overwhelm the lungs and kill its host.

SourceNorthwestern University·JournalCell Host & Microbe·DateApr 14, 2014

US clean-air efforts stay on target

A Rice University analysis of state implementation plans reveals that most urban areas have met the next benchmark for reducing airborne particulate matter. The study found that PM 2.5 concentrations declined by an average 2.6 micrograms per cubic meter in regions that filed SIPs to attain the standard by 2009.

SourceRice University·JournalJournal of the Air & Waste Management Association·DateMar 27, 2014

New research links body clocks to chronic lung diseases

Scientists at The University of Manchester discovered a rhythmic defence pathway in the lung controlled by our body clocks, essential for combating toxins and pollutants. The research found that timed administration of antioxidant compounds according to the lung clock time can increase their effectiveness and reduce side effects.

SourceUniversity of Manchester·JournalGenes & Development·DateMar 17, 2014

Roy Castle lung cancer research funding

The Roy Castle Lung Cancer Foundation has funded two new projects at the University of Liverpool, one aiming to improve survival rates for UK lung cancer patients and the other focusing on developing an early blood test for diagnosis. The foundation has invested $20m in lung cancer research over 23 years.

Early detection helps manage a chronic graft-vs.-host disease complication

Researchers found that a simple questionnaire predicting lung involvement improves patient outcomes in chronic graft-vs.-host disease. A score of 3 indicates shortness of breath at rest or requiring oxygen, associated with higher mortality. Early detection enables timely treatment to reduce symptoms and improve survival.

SourceFred Hutchinson Cancer Center·JournalBiology of Blood and Marrow Transplantation·DateMar 6, 2014

New clues found to preventing lung transplant rejection

Researchers found that memory T cells play a crucial role in lung transplant acceptance, suggesting that current immune-suppression strategies may contribute to organ rejection. The study aims to develop new strategies to selectively target immunosuppression in lung transplants and boost the ability of memory T cells.

SourceWashU Medicine·JournalJournal of Clinical Investigation·DateFeb 25, 2014

JCI early table of contents for Feb. 24, 2014

Researchers found that PPAR-γ agonists can reverse emphysema development despite continuous exposure to cigarette smoke. Additionally, a compound enhancing glutamate uptake improved ALS symptoms and extended lifespan in mice. Increased autophagy also contributed to BRAF inhibitor resistance in melanoma patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 24, 2014